Shelley Hartman

Shelley Hartman

Company: Aegle Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Chair’s Opening Remarks 9:00 am

Read more

day: Conference Day One

Roundtable Discussion: Future Directions & Predictions for Exosome Space with Regulatory Confidence 3:45 pm

More practical and highly interactive breakout roundtables where attendees can crowdsource solutions and share opinions around pre-assigned topic areas. A valuable chance for attendees to unite around hot topics and debate best practice. This is a dedicated opportunity for you to voice your experience and identify unique solutions.Read more

day: Conference Day One

Chairs Closing Remarks 4:45 pm

Read more

day: Conference Day One

Roundtable Discussion: Evaluating Exosomes Based Products for Diagnosis, Drug Delivery & Therapeutics 3:30 pm

Understanding the advantages and limitations of engineering exosomes as therapeutics and as drug delivery vehicles Linking engineering to the successful loading of cargo artificially Enhancing future pipelines using comparison of results Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.